Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease. [electronic resource]
Producer: 20091215Description: 456-65 p. digitalISSN:- 1873-7544
- Animals
- Arachidonic Acids -- metabolism
- Binding, Competitive -- drug effects
- Brain -- metabolism
- Cannabinoid Receptor Modulators -- metabolism
- Cannabinoids -- pharmacology
- Corpus Striatum -- metabolism
- Disease Models, Animal
- Down-Regulation -- physiology
- Dyskinesias -- etiology
- Endocannabinoids
- Glycerides -- metabolism
- Hippocampus -- metabolism
- Huntington Disease -- metabolism
- Mice
- Mice, Inbred C57BL
- Mice, Inbred CBA
- Mice, Transgenic
- Polyunsaturated Alkamides -- metabolism
- RNA, Messenger -- metabolism
- Receptor, Cannabinoid, CB1 -- drug effects
- Receptors, Dopamine -- drug effects
- Substantia Nigra -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.